| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/16/2004 | WO2004108888A2 Micropositioning cells for tissue engineering |
| 12/16/2004 | WO2004108887A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 12/16/2004 | WO2004108765A2 Extracellular aspergillus polypeptides |
| 12/16/2004 | WO2004108762A1 Immobilized membrane proteins and methods of use therefor |
| 12/16/2004 | WO2004108756A2 Sars coronavirus peptides and uses thereof |
| 12/16/2004 | WO2004108754A2 Herpes simplex virus us11 protein and hipk2 protein complexes and uses thereof |
| 12/16/2004 | WO2004108749A2 Binding peptides: methods for their generation and use |
| 12/16/2004 | WO2004108743A2 Support comprising immobilised carbohydrate molecules and its use |
| 12/16/2004 | WO2004108160A1 Osteogenesis-promotion enhancer and method of screening the same |
| 12/16/2004 | WO2004108142A2 Inhibitors of tip-1 for treatment tissue damage |
| 12/16/2004 | WO2004108079A2 Parkin-interacting proteins |
| 12/16/2004 | WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/16/2004 | WO2004108065A2 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies |
| 12/16/2004 | WO2004108009A2 Method and kit for assessing risk for bovine respiratory disease |
| 12/16/2004 | WO2004107977A1 Systems for extracting bodily fluid and monitoring an analyte therein |
| 12/16/2004 | WO2004107970A1 Integrated test element for a one-time drawing and analyzing of a sample to be analyzed |
| 12/16/2004 | WO2004107958A2 Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 12/16/2004 | WO2004107863A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands |
| 12/16/2004 | WO2004097034A3 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4) |
| 12/16/2004 | WO2004094987A8 Kit for detecting endotoxin in aqueous solutions |
| 12/16/2004 | WO2004094459A3 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 12/16/2004 | WO2004091646A3 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction |
| 12/16/2004 | WO2004088282A3 Methods to control and/or predict rheological properties |
| 12/16/2004 | WO2004087955A8 Markers for roscovitine |
| 12/16/2004 | WO2004086041A3 Universal readout for target indentification using biological microarrays |
| 12/16/2004 | WO2004085433A3 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/16/2004 | WO2004081574A3 Detection, monitoring and treatment of cancer |
| 12/16/2004 | WO2004080374A3 Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) |
| 12/16/2004 | WO2004079345A3 Musculoskeletal assay |
| 12/16/2004 | WO2004076511A3 Photocrosslinked hydrogel surface coatings |
| 12/16/2004 | WO2004071379A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y10 (p2y10) |
| 12/16/2004 | WO2004070347A3 Screening for modulators of fat storage |
| 12/16/2004 | WO2004064735A3 Treatment of benign prostatic hyperplasia |
| 12/16/2004 | WO2004061423A3 Compositions and methods for diagnosing and treating colon cancers |
| 12/16/2004 | WO2004060917A3 Fluorescence based t-type channel assay |
| 12/16/2004 | WO2004060832B1 Fluorescent creatinine assay |
| 12/16/2004 | WO2004058287A3 Methods of treating neurological conditions with hematopoeitic growth factors |
| 12/16/2004 | WO2004042344A3 Fabrication of a high resolution biological molecule detection device with gold electrical conductors |
| 12/16/2004 | WO2004033062A3 Integrated sample cell and filter and system using same |
| 12/16/2004 | WO2004024300A8 Ultrafiltration membrane, device, bioartificial organ and methods |
| 12/16/2004 | WO2004013635A3 System and method for scoring peptide matches |
| 12/16/2004 | WO2004003156A3 Il-21 as a regulator of immunoglobin production |
| 12/16/2004 | WO2003104434A3 A method to amplify variable sequences without imposing primer sequences |
| 12/16/2004 | WO2003091407A3 Device and method for high-throughput quantification of mrna from whole blood |
| 12/16/2004 | WO2003080823A8 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 12/16/2004 | WO2003068932A3 Method for crystallizing human gsk3 and novel crystal structure thereof |
| 12/16/2004 | WO2003066802A9 Gene expression analysis using nicking agents |
| 12/16/2004 | WO2003056343B1 Method for protein expression analysis |
| 12/16/2004 | WO2003016485A3 Full-length serine protein kinase in brain and pancreas |
| 12/16/2004 | WO2003013425A9 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 12/16/2004 | WO2002061392A9 Method and apparatus for the confinement of materials in a micromachined chemical sensor array |
| 12/16/2004 | US20040255342 Animal model for identifying modulator to treat and/or prevent alzheimer's disease |
| 12/16/2004 | US20040255341 Transgenic flies expressing Abeta42-Arctic |
| 12/16/2004 | US20040254774 Model for mutually exclusive domain folding molecular switch |
| 12/16/2004 | US20040254744 Locating system of oxidation/reduction potential of electrolysis water and the constant output method of calibration and compensation thereof |
| 12/16/2004 | US20040254738 Method and system for organizing multiple objects of interest in field of interest |
| 12/16/2004 | US20040254737 Information processing apparatus, information processing method, storage medium and program |
| 12/16/2004 | US20040254736 Predictive toxicology for biological systems |
| 12/16/2004 | US20040254735 Method of performing three-dimensional molecular superposition and similarity searches in databases of flexible molecules |
| 12/16/2004 | US20040254732 Determining fluid composition from fluid properties |
| 12/16/2004 | US20040254513 Conductive polymer materials and applications thereof including monitoring and providing effective therapy |
| 12/16/2004 | US20040254434 Glucose measuring module and insulin pump combination |
| 12/16/2004 | US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 12/16/2004 | US20040254361 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof |
| 12/16/2004 | US20040254360 Molecular identification of staphylococcus-type bacteria |
| 12/16/2004 | US20040254355 Labeling reagents comprising aphenylic analogs of rhodamine dyes |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254349 Mycobacterial antigens expressed under low oxygen tension |
| 12/16/2004 | US20040254346 Human survivin interacting protein 1 (sip-1) |
| 12/16/2004 | US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/16/2004 | US20040254342 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors |
| 12/16/2004 | US20040254339 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 12/16/2004 | US20040254224 Medicaments |
| 12/16/2004 | US20040254153 Potentiation adenosine 3',5'-cyclic monophosphate in urogenital system of female |
| 12/16/2004 | US20040254148 Pharmaceutical composition effective in treatment of mechanical allodynia, screening method of potential compound as said pharmaceutical composition, inspection method of mechanical allodynia, and treatment method of mechanical allodynia |
| 12/16/2004 | US20040254135 Administering enzyme inhibitor; moderate metabolism |
| 12/16/2004 | US20040254132 Ovary-specific genes and proteins |
| 12/16/2004 | US20040254127 Using Chlamydia bacteria in mixture with carrier |
| 12/16/2004 | US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation |
| 12/16/2004 | US20040254110 Methods for diagnosing and treating Alzheimer's disease |
| 12/16/2004 | US20040254094 Antiproliferative agents for Dna virus |
| 12/16/2004 | US20040253745 Cvd assay |
| 12/16/2004 | US20040253744 Fluidic force discrimination |
| 12/16/2004 | US20040253743 Using diffusion coefficients and relaxation times to determine the constituents and viscosity of oil mixture |
| 12/16/2004 | US20040253739 Detection procedures for fibrinogen and/or fibrinogen derivatives |
| 12/16/2004 | US20040253738 Using scanning laser cytometry to identify and record aggregates in cell suspensions; DNA histogram analysis and tumor diagnosis |
| 12/16/2004 | US20040253736 Apparatus for monitoring glucose concentration in capillary blood |
| 12/16/2004 | US20040253735 Determining concentration of water in unrefined oil; peteroleum refining and feedstock analysis |
| 12/16/2004 | US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders |
| 12/16/2004 | US20040253728 New method |
| 12/16/2004 | US20040253726 Caged compound cleaving process |
| 12/16/2004 | US20040253715 Multicompartment apparatus for isolation and/or detection of preferential biopolymers in solution; food safety and animal husbandry |
| 12/16/2004 | US20040253711 Mycobacterial genes down-regulated during latency |
| 12/16/2004 | US20040253706 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040253705 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 12/16/2004 | US20040253691 Apparatus comprising piezoelectric layers for use in the separation of preferential blood cells or components from fluid blood |
| 12/16/2004 | US20040253685 eNOS mutations useful for gene therapy and therapeutic screening |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders |